Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tourmaline Bio Inc | 741,691 | 741,691 | 0 | $9.54M | $19.07M | 37.12% | +$9.53M |
| Jasper Therapeutics, Inc.(JSPR) | 928,964 | 928,964 | 0 | $21.09M | $17.47M | 34.02% | -$3.61M |
| Korro Bio, Inc.(KRRO) | 368,085 | 368,085 | 0 | $12.47M | $12.30M | 23.95% | -$165.6K |
| Hillevax Inc | 558,923 | 558,923 | 0 | $8.08M | $983.7K | 1.92% | -$7.10M |
| Ventyx Biosciences Inc | 412,225 | 412,225 | 0 | $952.2K | $898.7K | 1.75% | -$53.6K |
| Kezar Life Sciences Inc | 828,711 | 828,711 | 0 | $497.2K | $638.1K | 1.24% | +$140.9K |